sellModerate cluster of 3
Jewell Christopher M sold $875k of RNAC
Chief Scientific Officer at Cartesian Therapeutics, Inc.. 52,115 shares at an average of $16.79, traded Nov 14, 2024, filed Nov 18, 2024.
Warning score
58Value
$875k
52,115 shares
Holdings after
25,940
-84% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001453687-24-000128, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 14, 2024 | MOption exercise Common Stock | +36,050 | $3.23 | $116k | 61,990 | Nov 18, 2024 |
| Nov 14, 2024 | SOpen-market sale Common Stock | -18,550 | $16.34 | $303k | 43,440 | Nov 18, 2024 |
| Nov 14, 2024 | SOpen-market sale Common Stock | -17,500 | $17.02 | $298k | 25,940 | Nov 18, 2024 |
| Nov 15, 2024 | MOption exercise Common Stock | +16,065 | $3.23 | $52k | 42,005 | Nov 18, 2024 |
| Nov 15, 2024 | SOpen-market sale Common Stock | -16,065 | $17.06 | $274k | 25,940 | Nov 18, 2024 |
| Nov 14, 2024 | MOption exercise Stock Option (Right to Buy)derivative | -36,050 | - | - | 106,497 | Nov 18, 2024 |
| Nov 15, 2024 | MOption exercise Stock Option (Right to Buy)derivative | -16,065 | - | - | 90,432 | Nov 18, 2024 |
Related signals
Other insiders at Cartesian Therapeutics, Inc. and this insider’s other filings.
| Score | Side | Company | Insider | Value | Shares | Filed |
|---|---|---|---|---|---|---|
| 40Moderate | buy | RNAC Cartesian Therapeutics, Inc. | SPRINGER TIMOTHY A director, owner | $965k | 52,189 | |
| 20Weak | sell | RNAC Cartesian Therapeutics, Inc. | Kurtoglu Metin Chief Technology Officer | $345k | 13,664 | |
| 55Moderate | sell 3 | RNAC Cartesian Therapeutics, Inc. | Kurtoglu Metin Chief Technology Officer | $649k | 38,689 | |
| 59Moderate | sell 3 | RNAC Cartesian Therapeutics, Inc. | Miljkovic Milos Chief Medical Officer | $908k | 55,000 | |
| 60Notable | sell 3 | RNAC Cartesian Therapeutics, Inc. | Kurtoglu Metin Chief Technology Officer | $1.4M | 82,368 | |
| 43Moderate | buy | RNAC Cartesian Therapeutics, Inc. | SPRINGER TIMOTHY A director, owner | $7.4M | 431,940 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.